Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
N Engl J Med
    March 2026
  1. KOTANIDIS CP, Whelton PK, Wright CB
    Blood-Pressure Targets in Hypertension Management.
    N Engl J Med. 2026;394:1026-1029.
    >> Share

    February 2026
  2. BENETOS A, Gautier S, Rossignol P
    Reduction of Antihypertensive Treatment in Nursing Home Residents. Reply.
    N Engl J Med. 2026;394:932-933.
    >> Share

  3. FUJI S
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:932.
    >> Share

  4. ZHANG L, Yang L
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:931-932.
    >> Share

  5. HUART J, Jouret F
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:931.
    >> Share

  6. LU Y, Li L
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:930-931.
    >> Share

  7. STRANDBERG TE
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:930.
    >> Share

  8. FADAKAR PK, Pourvaziri A, Feldman AS, Pier DB, et al
    Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension.
    N Engl J Med. 2026;394:700-709.
    >> Share

    January 2026
  9. KISHORE SP, Kocher R
    The Hypertension Control Paradox - Why Is America Stuck?
    N Engl J Med. 2026;394:417-420.
    >> Share

  10. HORTON JC
    Idiopathic Intracranial Hypertension. Reply.
    N Engl J Med. 2026;394:414-415.
    >> Share

  11. WANG Y, Liang Z, Weng D
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    >> Share

  12. XIAO YJ, Sun H
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    >> Share

  13. DO LAGO V, Caldas J
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    >> Share

  14. FLACK JM, Dwyer JP, Williams B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. Reply.
    N Engl J Med. 2026;394:305-306.
    >> Share

  15. JHAVERI KD, Hirsch JS, Fishbane S
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:305.
    >> Share

  16. ZHENG Z, Jiang X, Wu B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    >> Share

  17. HIGASHI Y
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    >> Share

  18. PEDREIRA-BOUZAS J, Pousada-Fonseca A
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:303-304.
    >> Share

    November 2025
  19. GOREY S, Rothberg M, Chang TI
    To Treat or Not to Treat? Watchful Waiting or Oral Antihypertensives for Asymptomatic Inpatient Hypertension.
    N Engl J Med. 2025;393:2051-2053.
    >> Share

  20. PLACIDO R, Baptista B
    Ortner's Syndrome in Pulmonary Hypertension.
    N Engl J Med. 2025;393:e35.
    >> Share

  21. JIMENEZ C, Andreassen M, Durand A, Moog S, et al
    Belzutifan for Advanced Pheochromocytoma or Paraganglioma.
    N Engl J Med. 2025;393:2012-2022.
    >> Share

    October 2025
  22. HORTON JC
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2025;393:1409-1419.
    >> Share

    September 2025
  23. MCLAUGHLIN VV, Hoeper MM, Badesch DB, Ghofrani HA, et al
    Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
    N Engl J Med. 2025 Sep 30. doi: 10.1056/NEJMoa2508170.
    >> Share

  24. SIEDNER MJ, Magula N, Mazibuko L, Sithole N, et al
    Home-Based Care for Hypertension in Rural South Africa.
    N Engl J Med. 2025 Sep 1. doi: 10.1056/NEJMoa2509958.
    >> Share

    August 2025
  25. FLACK JM, Azizi M, Brown JM, Dwyer JP, et al
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2507109.
    >> Share

  26. GUZIK TJ, Tomaszewski M
    Aldosterone Synthase Inhibition for Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMe2511533.
    >> Share

  27. BENETOS A, Gautier S, Freminet A, Metz A, et al
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2508157.
    >> Share

  28. LAFFIN LJ, Rodman D, Nissen SE
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension. Reply.
    N Engl J Med. 2025;393:726-727.
    >> Share

  29. POLLOCK JM 3RD
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:726.
    >> Share

  30. BURGOS E, Fernandez Fernandez B, Ortiz A
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:725-726.
    >> Share

    June 2025
  31. GARVEY WT, Bluher M, Osorto Contreras CK, Davies MJ, et al
    Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2025 Jun 22. doi: 10.1056/NEJMoa2502081.
    >> Share

    May 2025
  32. MARON BA
    Sotatercept and the Clinical Transformation of Pulmonary Arterial Hypertension.
    N Engl J Med. 2025;392:2059-2061.
    >> Share

    April 2025
  33. LAFFIN LJ, Kopjar B, Melgaard C, Wolski K, et al
    Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
    N Engl J Med. 2025 Apr 23. doi: 10.1056/NEJMoa2501440.
    >> Share

    March 2025
  34. HUMBERT M, McLaughlin VV, Badesch DB, Ghofrani HA, et al
    Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
    N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2415160.
    >> Share

  35. MAGNUSSEN C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, et al
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879.
    >> Share

    January 2025
  36. VAIDYA A, Morlote M, Moussa M, Barletta J, et al
    Targeting a Hormonal Cause of Hypertension.
    N Engl J Med. 2025;392:e14.
    >> Share

    November 2024
  37. BI Y, Li M, Liu Y, Li T, et al
    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412006.
    >> Share

    June 2024
  38. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:2227.
    >> Share

    May 2024
  39. NAJEM M, Dong E
    Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
    N Engl J Med. 2024;390:e47.
    >> Share

  40. LI G, Lin Y, Yang J, Anderson CS, et al
    Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMoa2314741.
    >> Share

  41. EDLOW JA
    Lowering Blood Pressure in Stroke Patients in the Ambulance - A Bridge Too Close?
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMe2402356.
    >> Share

    April 2024
  42. KUROLAP A, Chai Gadot C, Baris Feldman H
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis. Reply.
    N Engl J Med. 2024;390:1539-1540.
    >> Share

  43. ABASSI Z, Azzam ZS, Heyman SN
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1539.
    >> Share

  44. GLADYSHEVA IP, Wang D, Reed GL
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1538-1539.
    >> Share

  45. DOMINY J, Koch C, Lamarche L, Denning D, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1537-1538.
    >> Share

  46. CHEN B, Wei M
    Aortic Coarctation.
    N Engl J Med. 2024;390:1420.
    >> Share

  47. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    >> Share

    December 2023
  48. JAUREGUI R, Busis NA
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2023;389:2467.
    >> Share

    November 2023
  49. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2023;389:1685-1692.
    >> Share

    October 2023
  50. DESAI AS, Sweetser MT, Bakris GL
    Zilebesiran for Hypertension. Reply.
    N Engl J Med. 2023;389:1439-1440.
    >> Share

  51. VAN TWIST DJL, Kalic H
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438-1439.
    >> Share

  52. LIFSCHITZ M
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    >> Share

  53. ABASHEVA D, Fernandez-Fernandez B, Ortiz A
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016